admin

Antiretroviral Drugs for HIV: Mechanisms, Current Regimens, Interactions and Safety

Medical education review; updated 10 November 2026. Regimens must be individualized and checked against local guidelines. Overview Antiretroviral therapy (ART) suppresses HIV replication, restores immune function and prevents HIV-related disease. Sustained viral suppression also prevents sexual transmission. ART should be offered to everyone diagnosed with HIV and selected using resistance history, hepatitis B status, comorbidities,…

Read Full News

Antiviral Drugs: Mechanisms, Indications, Clinical Evidence and Safety

Medical education review; updated 10 November 2026. Regimens must be individualized and checked against local guidelines. Overview Antiviral drugs target specific viral enzymes or replication stages; they do not work interchangeably across viral infections. Selection depends on the infecting virus, disease severity, timing, host immune status, resistance and renal/hepatic function [1,2]. Classification and mechanisms Herpesviruses:…

Read Full News

Antifungal Drugs: Classes, Mechanisms, Clinical Uses and Adverse Effects

Medical education review; updated 10 November 2026. Regimens must be individualized and checked against local guidelines. Overview Antifungal selection requires knowing the organism, infection site, severity, host immune status and local susceptibility patterns. Superficial dermatophyte disease differs substantially from candidemia, cryptococcal meningitis and invasive aspergillosis [1–3]. Major drug classes and mechanisms Azoles: fluconazole, itraconazole, voriconazole,…

Read Full News

Antileprosy Drugs: WHO Multidrug Therapy, Mechanisms and Monitoring

Medical education review; updated 10 November 2026. Regimens must be individualized and checked against local guidelines. Overview Leprosy (Hansen disease) is a chronic infection caused by Mycobacterium leprae and, less commonly, M. lepromatosis, affecting skin and peripheral nerves. Early diagnosis, multidrug therapy (MDT), nerve assessment and management of inflammatory reactions prevent disability [1]. Classification and…

Read Full News

Antitubercular Drugs: Mechanisms, Modern TB Regimens and Safety

Medical education review; updated 10 November 2026. Regimens must be individualized and checked against local guidelines. Overview Tuberculosis (TB) treatment requires combinations of active drugs to cure disease and prevent acquired resistance. Regimen selection depends on drug-susceptibility testing, anatomic site, age, pregnancy, HIV status, prior treatment and local TB program guidance [1,2]. First-line pharmacology Isoniazid…

Read Full News

Tetracyclines and Chloramphenicol: Mechanisms, Clinical Uses and Safety

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Tetracyclines are protein-synthesis inhibitors used for selected respiratory, tick-borne, sexually transmitted and dermatologic infections. Chloramphenicol, a distinct 50S inhibitor, is now reserved for unusual situations because of serious hematologic toxicity [1–3]. Classification and mechanism…

Read Full News

Aminoglycoside Antibiotics: 30S Mechanism, PK/PD, Monitoring and Toxicity

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Aminoglycosides are rapidly bactericidal, concentration-dependent antibiotics chiefly used for susceptible aerobic Gram-negative bacterial infections and selected combination regimens. Their narrow therapeutic index makes susceptibility testing, renal assessment and drug-level monitoring central to safe use…

Read Full News

Macrolide Antibiotics: Ribosomal Action, Clinical Uses, Resistance and QT Safety

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Macrolides include erythromycin, clarithromycin and azithromycin. They inhibit bacterial protein synthesis and remain useful for certain atypical respiratory pathogens, pertussis and selected other infections; widespread resistance limits empiric use for some syndromes [1–3]. Classification…

Read Full News

Fluoroquinolones: DNA Gyrase Inhibition, Clinical Indications and Serious Warnings

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Fluoroquinolones are synthetic, concentration-dependent bactericidal antibiotics that inhibit bacterial type II topoisomerases. Their favorable oral absorption must be weighed against resistance and potentially severe adverse effects; they are not routine first-line agents for minor…

Read Full News

Sulfonamides and Cotrimoxazole: Folate Inhibition, Clinical Uses and Monitoring

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Antibacterial sulfonamides were among the earliest effective systemic antibiotics. Cotrimoxazole combines sulfamethoxazole (SMX), a sulfonamide, with trimethoprim (TMP), a diaminopyrimidine, not a second sulfonamide. Their sequential blockade of folate synthesis provides activity against selected…

Read Full News